Home » Topics » Regulatory » Health Canada

Health Canada
RSS

ViaCyte cleared to begin trial of PEC-Direct in U.S. and Canada

May 23, 2017

Health Canada approves Roche's cobas EGFR Mutation Test v2

March 16, 2017

Canada first to approve Kevzara

Feb. 1, 2017

VBI Vaccines cleared to begin phase I study of CMV vaccine candidate in Canada

June 27, 2016

Antibe Therapeutics cleared to begin phase II study of ATB-346

March 7, 2016

Takeda's NDS for ixazomib accepted for priority review in Canada

Feb. 18, 2016

Tobira Therapeutics initiates a program to evaluate cenicriviroc for the treatment of PSC

Jan. 12, 2016

ExCellThera cleared to begin phase I/II trial of ECT-100 for expansion of hematopoietic stem cells

Dec. 23, 2015

Health Canada approves Cingal for osteoarthritis knee pain

Nov. 5, 2015

Xenon initiates phase I trial of XEN-801 for acne

Sep. 29, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
CTAD 2025: The challenges of combination therapies for dementia
BioWorld Science
At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...